Floatz logo

CARVEDILOL

Cirrhotic Cardiomyopathy

Post Graduate Institute of Medical Education and Research, ChandigarhSmall moleculePhase 4 / ApprovedActive
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Cirrhotic Cardiomyopathy cohort.

Asset / SponsorPhaseRating
Empagliflozin
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4BB
METOPROLOL
University of Sao Paulo
Phase 3B
SIMVASTATIN
Post Graduate Institute of Medical Education and Research, Chandigarh
N/AD
DL-DOBUTAMINE
Hvidovre University Hospital
D
IVABRADINE
Post Graduate Institute of Medical Education and Research, Chandigarh
N/AD

Same molecule, other indications

CARVEDILOL is also rated in:

portal hypertensionDormant
BBB
Indicative ·
76 / 100
View asset →
esophageal varicesDormant
BBB
Indicative ·
73 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →